OpenLobby.EU
Explore

CEVA Santé Animale

Ceva Santé Animale discovers, develops, manufactures and markets veterinary vaccines and medicines globally, supported by technical services.

Lobbying Activity

Meeting with Alisa Tiganj (Cabinet of Commissioner Christophe Hansen), Antonella Rossetti (Cabinet of Commissioner Christophe Hansen) and

29 Apr 2025 · Role of animal health sector in contributing to a sustainable livestock sector in the EU; Trade and animal health and agricultural policies; Upcoming livestock strategy: content and timeline; Digitalisation in support of farmers

Response to Use of veterinary medicinal products for diseases in terrestrial animals

2 Sept 2022

Ceva Santé Animale welcomes the draft of the delegated act. On Avian Inluenza, it is important to note that surveillance under vaccination conditions will be a heavy task for national veterinary services. Therefore we would like to propose the following change in the Annexes p. 35 para 2.2 ( see original text below) after the start of vaccination, the following active surveillance has to be carried out by an official veterinarian in vaccinated establishments at least every 30 days to detect occurrence of infection with HPAI field virus: We would suggest to replace " by an official veterinarian" by " under the supervision of an offical veterinarian" We would also like to mention that new generation vaccines against Rift Valley Fever are a very important tool for the future control of this disease and should be given full consideration in this delegated act
Read full response

Meeting with Jérémy Decerle (Member of the European Parliament)

6 Apr 2022 · Grippe aviaire

Meeting with Marco Valletta (Cabinet of Commissioner Vytenis Andriukaitis) and Syntex

15 May 2018 · Animal welfare

Meeting with Marco Valletta (Cabinet of Commissioner Vytenis Andriukaitis)

24 Nov 2017 · Horse welfare in South America